Mucin‐fused myeloid‐derived growth factor (MYDGF164) exhibits a prolonged serum half‐life and alleviates fibrosis in chronic kidney disease
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Pharmacology"
DOI: 10.1111/bph.15851
Abstract: Although no effective therapy is available to stop or reverse CKD progression targeting its key feature, the loss of peritubular capillaries (PTCs) leading to interstitial fibrosis, myeloid‐derived growth factor (MYDGF) with tissue‐repairing activities enlightens its… read more here.
Keywords: derived growth; myeloid derived; growth factor; mucin fused ... See more keywords